-
Good news - FACI magnesium stearate is activated!
Time of Update: 2022-04-16
Through these years of continuous development, Faci has gradually grown into a leader in the global oleochemical product market, and has established extensive and stable cooperative relations with customers in petrochemical, PVC, rubber, food, pharmaceutical, cosmetics and other industries.
-
CDE's new regulations speed up the launch of innovative drugs!
Time of Update: 2022-04-16
From the relevant requirements of the "Working Procedures", we can see that CDE strengthens the communication of the whole process, improves the efficiency of completing clinical trials, and focuses on supporting and accelerating the specific practice of high-value new drug research and development .
-
Notice on Public Solicitation of Opinions on "<Technical Guidelines for Clinical Trials of Improved New Drugs of Chemical Drugs> Questions and Answers (Draft for Comments)"
Time of Update: 2022-04-16
pdf 2 Drafting Instructions for "Questions and Answers on Technical Guiding Principles for Clinical Trials of Improved New Drugs of Chemical Drugs (Draft for Comment)".
pdf 3 Questions and Answers on Technical Guiding Principles for Clinical Trials of Improved New Drugs of Chemical Drugs (Draft for Comment) Feedback Form.
-
Digitalization is coming, how do top pharmaceutical companies such as Merck, Pfizer, Sanofi, and Takeda come out on top in the competition?
Time of Update: 2022-04-16
As an established pharmaceutical company, Pfizer has shown great enthusiasm for digital transformation, and has made attempts in AI+ drug research and development, big data, digital marketing, and patient services .
-
"The first stock of HPV vaccine on the Hong Kong Stock Exchange" exploded!
Time of Update: 2022-04-16
Facing the blue ocean market, domestic HPV vaccine companies are on the rise, and several nine-valent pipelines have advanced to Phase III clinical trials.
. Whether it can occupy the first-mover advantage of the first domestic nine-valent HPV vaccine is very important for Ruike Bio .
-
Brief analysis of centralized collection varieties: meropenem.
Time of Update: 2022-04-16
The market is not big, there are many snatchers Brief analysis of centralized collection varieties: Terbutaline inhalation .
There is no price, the market is difficult to guarantee Brief analysis of the collection varieties: methylprednisolone injection .
-
BIPS 2nd Global Biomedical Innovation Pioneer China Summit 2022
Time of Update: 2022-04-16
·The summit includes two parallel forums, namely, the Pioneer Forum of Biomedical R&D Innovation and the Pioneer Forum of Biopharmaceutical Process Innovation .
-
The sales policy of four types of epidemic monitoring drugs is loosened!
Time of Update: 2022-04-16
In order to strengthen the prevention and control of the new crown pneumonia epidemic, in early 2020, Guangdong Province took the lead in requiring all retail pharmacies to implement a registration and reporting system when selling fever and cough medicines.
-
Yangzijiang grabbed the first imitation of Shugeng Sodium Glucose, and Cinda’s revenue was 4.2 billion and a loss of 3.1 billion
Time of Update: 2022-04-16
According to Yaohai data, the sales of the original research have grown rapidly since the launch, reaching nearly 300 million yuan last year .
According to data estimates, the sales in 2021 will be about 3 billion yuan, and the cumulative sales of the product since its launch will be about 6.
-
GAP restarts!
Time of Update: 2022-04-16
(Reporter Li Yao from this newspaper) In January 2022, the "14th Five-Year Plan" National Planting Industry Development Plan issued by the Ministry of Agriculture and Rural Affairs put forward a goal: by 2025, the area of traditional Chinese medicinal materials in the country will be stabilized at about 45 million mu, The area of authentic medicinal materials accounts for more than 50% of the total area .
-
[Dry goods] Analysis of the formulation process of generic drug quality standards
Time of Update: 2022-04-16
Selection of quality research items and preliminary determination of methods: It can be called the preliminary establishment of draft quality standards (this work should be completed before the compa
-
50 major retail varieties are included in price monitoring!
Time of Update: 2022-04-16
In 2020, the total sales of acarbose tablets in Chinese public medical institutions and Chinese urban physical pharmacy terminals will exceed 5 billion yuan, and it is the best-selling oral hypoglycemic drug in China .
-
Coron is on the hook!
Time of Update: 2022-04-16
Highlights Recently, Kelun Pharmaceutical has made new progress in research and development: the marketing application of troglitatin succinate tablets has entered the approval process, and the omega
-
The whole process of traditional Chinese medicine decoction pieces can be traced back to the local pilot, and the non-traceable decoction pieces may be gradually abandoned, and the 100 billion market will be reshuffled!
Time of Update: 2022-04-16
Recently, Shanghai issued the "Notice on Carrying out the Pilot Work of Clinical Application of Whole-process Traceability of Traditional Chinese Medicine Pieces in the City", selected 5 well-known Chinese medicine hospitals and 8 pharmaceutical companies in Shanghai as pilots, supported the use of traceable pieces, and encouraged high quality and good prices.
-
Live Preview Solutions for Challenging APIs in Direct Pressure Processes
Time of Update: 2022-04-16
Solutions for Challenging APIs in Direct Pressure Processes Beijing time: Thursday, March 10, 2022 16:00-17:30 Live address: Click to register to participate activity descriptionThis webinar was conducted by technical experts from Budenheim, Germany, a preferential supplier, in a live online broadcast.
-
CDE publishes "Guidelines for Drug Registration Acceptance Review (Draft for Comment)"
Time of Update: 2022-04-16
On February 18, CDE issued the "Guidelines for the Acceptance and Review of Drug Registration (Trial) (Draft for Comment)", soliciting opinions on three aspects: traditional Chinese medicine, chemical drugs, and biological products.
-
The first!
Time of Update: 2022-04-16
There are 5 TPO-R agonist drugs listed in China Primary immune thrombocytopenia (ITP) is a rare, severe autoimmune disorder characterized by low platelet counts in the blood that can lead to serious bleeding events .
-
The shortage of raw materials in China has made it worse, this time is related to the conflict between Russia and Ukraine!
Time of Update: 2022-04-16
Statistics from China COFCO show that in the past 6 years, China's corn starch production has been increasing year by year .
In the past 10 years, Ukraine, known as the "granary of Europe", has gradually become a new source of imported corn for China .
-
Merck completes acquisition of biopharmaceutical CDMO company Exelead and plans to invest more than 500 million euros to enhance technical capabilities
Time of Update: 2022-04-16
Merck plans to continue investing in Exelead over the next decade Following the newly established Life Sciences CDMO (Contract Development and Manufacturing Organization) business unit, the acquisit
-
Exclusive writing: Take your time when the original research of generic drugs replaces the project!
Time of Update: 2022-04-16
Judging from the performance of the hospital market, paclitaxel for injection (albumin-bound) exceeded 3 billion yuan for the first time in the fourth quarter of 2019, and the market size has also stabilized at about 3 billion yuan after entering the centralized procurement.
